Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Publication Date: April 25, 2019
Last Updated: December 15, 2022
Treatment
Recommendations for ophthalmic screening
In children and adolescents with JIAb at high risk of developing uveitis: - Ophthalmic screening every 3 months is conditionally recommended.
( Conditional , Very Low ) 607
Recommendations for ophthalmic monitoring
Tapering or discontinuing topical glucocorticoids, ophthalmic monitoring within 1 month after each change of topical glucocorticoids is strongly recommended over monitoring less frequently. ( Strong , Very Low )
607
Title
Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Authoring Organization
American College of Rheumatology